Parekh N, Zou A P
Department of Physiology, University of Heidelberg, Germany.
Am J Physiol. 1996 Sep;271(3 Pt 2):F653-8. doi: 10.1152/ajprenal.1996.271.3.F653.
This study investigated effects of renal prostaglandins and their interaction with different vasoactive agents in regulating regional renal blood flow. Using intravenous infusions, we compared effects of different pressor hormones and a nitric oxide (NO) inhibitor under control conditions and after inhibition of cyclooxygenase. Because vasodilator effects of prostanoids are considered to be mediated via opening of ATP-dependent K+ channels, we also studied effects of a prostacyclin analogue (iloprost), a channel opener (lemakalim), and a channel blocker (glibenclamide). Blood flow in renal cortex (CBF) and medulla (MBF) was determined with previously described platinum electrodes inserted into the kidney of anesthetized rats. Angiotensin II and norepinephrine reduced predominantly only CBF (-24 and -19%, respectively). After indomethacin, which selectively reduced MBF (-25%), angiotensin II and norepinephrine also reduced MBF (-45 and -35%, respectively), whereas the corresponding changes in CBF were not affected by indomethacin. Arginine vasopressin and the NO inhibitor NG-nitro-L-arginine methyl ester reduced both CBF and MBF by approximately 30% both under control conditions and after indomethacin. Iloprost and lemakalim increased selectively MBF (15 and 27%, respectively), whereas glibenclamide selectively decreased MBF (-19%). Our data indicate that renal prostaglandins are predominantly involved in regulating medullary circulation. They probably exert their dilatory action on medullary vessels via opening of ATP-dependent K+ channels and are involved in antagonizing medullary effects of pressor hormones in an agonist-specific manner.
本研究调查了肾前列腺素及其与不同血管活性药物的相互作用在调节肾局部血流中的作用。通过静脉输注,我们比较了在对照条件下以及环氧化酶抑制后不同升压激素和一氧化氮(NO)抑制剂的作用。由于前列腺素的血管舒张作用被认为是通过ATP依赖性钾通道的开放介导的,我们还研究了前列环素类似物(伊洛前列素)、通道开放剂(雷马卡林)和通道阻滞剂(格列本脲)的作用。使用先前描述的铂电极插入麻醉大鼠的肾脏来测定肾皮质血流量(CBF)和髓质血流量(MBF)。血管紧张素II和去甲肾上腺素主要仅降低CBF(分别为-24%和-19%)。在选择性降低MBF(-25%)的吲哚美辛处理后,血管紧张素II和去甲肾上腺素也降低了MBF(分别为-45%和-35%),而CBF的相应变化不受吲哚美辛影响。在对照条件下以及吲哚美辛处理后,精氨酸加压素和NO抑制剂NG-硝基-L-精氨酸甲酯均使CBF和MBF降低约30%。伊洛前列素和雷马卡林选择性增加MBF(分别为15%和27%),而格列本脲选择性降低MBF(-19%)。我们的数据表明,肾前列腺素主要参与调节髓质循环。它们可能通过ATP依赖性钾通道的开放对髓质血管发挥舒张作用,并以激动剂特异性方式参与拮抗升压激素的髓质效应。